Vaporous hyperoxia therapy

Vaporous hyperoxia therapy (also known as VHT, former O2Misly) is a wound treatment made of a combination of adiabatic vapor and elevated oxygen concentration in a medical environment. The purpose of this therapy is to treat hard-to-heal wounds like diabetic foot sores, burns, punctures and infected war wounds of veterans. It was originally developed by Adrian Pelkus, founder of Cure Care Inc.
Objectives of VHT
A recalcitrant, or non-healing wound is defined by failing to progress with standard therapy within a defined time period.. This definition applies the same to all types of wounds whether acute and chronic. VHT can be considered an adjunctive therapy and treatment option which may be prescribed as a complement to standard wound care (SWC). The objective is to stimulate wound healing by administering a mixture of vapor containing a general purpose disinfectant and then elevating oxygen concentrations over the course of treatment. VHT therapy has been studied and shown to have a significantly higher healing rate than SWC. The study also shows a reduction in treatment costs for lower leg wounds.
Reception of VHT
In 2013 VHT was given an award for "Life Changing" Technology from The Biocom Institute, a non-profit organization based in San Diego, California that links learning institutions and life science companies.
VHT has been granted three patents covering the technology, with a fourth patent pending, and a PST filed.
* 1) , 2) , 3)
* Cure Care, Inc. Wins the Biocom 2013 Award for “Life Changing” Technology.
Alternative treatments
Over several decades of research, wound treatment has significantly evolved and covered a number of alternatives. These alternatives may involve bandages, antibiotics, debridement, platelet-rich fibrin therapy, Hyperbaric oxygen therapy and Cell therapy. The following gives a brief description of these alternative therapies.
Wound dressings therapy
Absorptive fillers, hydrogel dressings, and hydrocolloids dressings are used to treat diabetic foot ulcers. In particular, hydrogels provide moisture to extensively dry wounds, facilitate autolysis and are helpful in dealing with ulcers with necrotic tissue. Hydrocolloid dressings are known to be absorbent, lightly permeable to vapor, and occlusive to wound exudate. PRF represents a revolution in the evolution of platelet gel therapy because it does not require any gelifying agent nor centrifugation of additive-free natural blood. Here the activity of fibrin molecules is sufficient to induce significant cicatricial properties of the PRF.
Hyperbaric oxygen therapy (HBO)
hyperbaric oxygen therapy (HBO) involves breathing pure oxygen in a pressurized room. It is known to treat serious infections, bubbles of air in blood vessels, and hard-to-heal wounds from diabetes or radiation injury. For patients with diabetic foot ulcers, this therapy reduces the risk of amputation.
Cell therapy
Cell therapy also known as cellular therapy or cytotherapy, is a new alternative to traditional methods of wound healing. A number of studies have demonstrated that stem cell therapy can be used safely and effectively in healing wounds. Stem cells can also be used to stimulate the growth of human tissues in healing diabetic foot ulcers.

Main Menu

See Also

Main Menu